Cardiovascular Systems Inc (NASDAQ:CSII) – Research analysts at Leerink Swann issued their Q1 2019 earnings per share estimates for shares of Cardiovascular Systems in a research note issued to investors on Sunday. Leerink Swann analyst D. Antalffy anticipates that the medical device company will earn ($0.05) per share for the quarter. Leerink Swann also issued estimates for Cardiovascular Systems’ Q2 2019 earnings at $0.00 EPS, Q3 2019 earnings at $0.09 EPS and Q4 2019 earnings at $0.10 EPS.

CSII has been the subject of a number of other research reports. Zacks Investment Research downgraded Cardiovascular Systems from a “hold” rating to a “sell” rating in a research report on Tuesday, October 10th. Citigroup began coverage on Cardiovascular Systems in a research report on Thursday, September 21st. They set a “market perform” rating for the company. Raymond James Financial began coverage on Cardiovascular Systems in a research report on Friday, September 22nd. They set a “market perform” rating for the company. Needham & Company LLC restated a “buy” rating and set a $36.00 target price (down previously from $37.00) on shares of Cardiovascular Systems in a research report on Thursday, October 26th. Finally, BidaskClub downgraded Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a research report on Friday, August 18th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $38.00.

Shares of Cardiovascular Systems (CSII) traded up $0.24 during mid-day trading on Wednesday, hitting $24.99. The company’s stock had a trading volume of 145,429 shares, compared to its average volume of 269,770. The company has a debt-to-equity ratio of 0.18, a current ratio of 4.30 and a quick ratio of 3.83. Cardiovascular Systems has a 52 week low of $23.00 and a 52 week high of $33.11. The company has a market cap of $836.66, a P/E ratio of 1,226.00 and a beta of 2.52.

Cardiovascular Systems (NASDAQ:CSII) last announced its quarterly earnings data on Wednesday, October 25th. The medical device company reported ($0.06) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.02. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The company had revenue of $49.70 million during the quarter, compared to the consensus estimate of $51.00 million. During the same quarter last year, the company earned ($0.06) EPS. The company’s quarterly revenue was down .2% on a year-over-year basis.

Institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. raised its position in Cardiovascular Systems by 12.6% in the 2nd quarter. Vanguard Group Inc. now owns 1,864,604 shares of the medical device company’s stock valued at $60,096,000 after purchasing an additional 208,248 shares during the last quarter. Cortina Asset Management LLC raised its position in Cardiovascular Systems by 5.0% in the 3rd quarter. Cortina Asset Management LLC now owns 872,363 shares of the medical device company’s stock valued at $24,557,000 after purchasing an additional 41,496 shares during the last quarter. State Street Corp raised its position in Cardiovascular Systems by 0.9% in the 2nd quarter. State Street Corp now owns 677,462 shares of the medical device company’s stock valued at $21,828,000 after purchasing an additional 6,074 shares during the last quarter. Point72 Asset Management L.P. raised its position in Cardiovascular Systems by 132.7% in the 3rd quarter. Point72 Asset Management L.P. now owns 469,978 shares of the medical device company’s stock valued at $13,230,000 after purchasing an additional 267,988 shares during the last quarter. Finally, New York State Common Retirement Fund raised its position in Cardiovascular Systems by 4.9% in the 3rd quarter. New York State Common Retirement Fund now owns 464,811 shares of the medical device company’s stock valued at $13,084,000 after purchasing an additional 21,507 shares during the last quarter. Institutional investors and hedge funds own 75.05% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Q1 2019 Earnings Forecast for Cardiovascular Systems Inc (CSII) Issued By Leerink Swann” was reported by American Banking News and is the property of of American Banking News. If you are reading this story on another website, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this story can be read at https://www.americanbankingnews.com/2017/12/13/q1-2019-earnings-forecast-for-cardiovascular-systems-inc-csii-issued-by-leerink-swann.html.

Cardiovascular Systems Company Profile

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Earnings History and Estimates for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with MarketBeat.com's FREE daily email newsletter.